PATIENTS’ PERSPECTIVE OF THE IMPACT OF CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD QUALITATIVE STUDY

https://storage.unitedwebnetwork.com/files/1099/3553e1261e834d07bdc72d4fa6bfd785.pdf
PATIENTS’ PERSPECTIVE OF THE IMPACT OF CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE DISCOVER CKD QUALITATIVE STUDY
Roberto
Pecoits Filho
Juan-Jesus Carrero-Roig Juan.Jesus.Carrero@ki.se Karolinska Institutet Department of Medical Epidemiology and Biostatistics Solna
Eiichiro Kanda kms.cds.kanda@gmail.com Kawasaki Medical School Department of Nephrology Kurashiki
Richard Ofori-Asenso richard.ofori-asenso@astrazeneca.com BioPharmaceuticals Medical, AstraZeneca Cardiovascular, Renal, Metabolism Epidemiology Cambridge
Ewelina Palmer ewelina.rzepa@astrazeneca.com AstraZeneca Patient Centered Science Cambridge
Andrew Linder andrewlinder@calibrationscc.com Calibrations Counseling & Consultation - Akron
Helen Woodward helenvwoodward@gmail.com Kidney Research UK Patient representative Peterborough
Surendra Pentakota surendra.pentakota@astrazeneca.com AstraZeneca BioPharmaceuticals Medical Cambridge
Juan Jose Garcia Sanchez juanjose.garciasanchez@astrazeneca.com BioPharmaceuticals Medical, AstraZeneca Global Market Access and Pricing Cambridge
Naoki Kashihara kashinao@med.kawasaki-m.ac.jp Kawasaki Medical School Department of Nephrology Kurashiki
Steven Fishbane sfishbane@northwell.edu Zucker School of Medicine Division of Nephrology Hempstead
Roberto Pecoits-Filho roberto.pecoits@arborresearch.org Pontifical Catholic University of Parana School of Medicine Curitiba
David C. Wheeler d.wheeler@ucl.ac.uk University College London Department of Renal Medicine London